Clinical Development and Research

The Clinical Development and Research team at Minervax is responsible for designing, implementing, and managing clinical trials to assess the safety and efficacy of the novel Group B Streptococcus vaccine. This multidisciplinary team collaborates on research initiatives, regulatory submissions, and operational strategies, ensuring compliance with industry standards while advancing vaccine development from preclinical through clinical phases. Their efforts are pivotal in bringing innovative solutions to market and improving public health.